Medscape
VIENNA, Austria — The appropriate dose of pancreatic enzyme replacement therapy (PERT) for exocrine pancreatic insufficiency (EPI) depends on the root cause of the insufficiency, according to results of a prospective study using European registry data. Specifically, patients with EPI due to pancreatic cancer or pancreatectomy need significantly more enzyme replacement than patients with insufficiency …
Read More
EPI: Optimal PERT Dose Varies by Primary Pancreatic Disease
Clora Center
23:39
VIENNA, Austria — The appropriate dose of pancreatic enzyme replacement therapy (PERT) for exocrine pancreatic insufficiency (EPI) depends on the root cause of the insufficiency, according to results of a prospective study using European registry data. Specifically, patients with EPI due to pancreatic cancer or pancreatectomy need significantly more enzyme replacement than patients with insufficiency
